E. Mahé

ORCID: 0000-0001-5780-1827
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Psoriasis: Treatment and Pathogenesis
  • Dermatology and Skin Diseases
  • Autoimmune Bullous Skin Diseases
  • Pharmaceutical studies and practices
  • Autoimmune and Inflammatory Disorders Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Skin Protection and Aging
  • Drug-Induced Adverse Reactions
  • Allergic Rhinitis and Sensitization
  • Complementary and Alternative Medicine Studies
  • Dermatological diseases and infestations
  • Nail Diseases and Treatments
  • Urticaria and Related Conditions
  • Cutaneous Melanoma Detection and Management
  • Cutaneous lymphoproliferative disorders research
  • Asthma and respiratory diseases
  • Oral Health Pathology and Treatment
  • Eosinophilic Disorders and Syndromes
  • Acne and Rosacea Treatments and Effects
  • Dermatological and COVID-19 studies
  • Nonmelanoma Skin Cancer Studies
  • Food Allergy and Anaphylaxis Research
  • Body Image and Dysmorphia Studies
  • Pregnancy and Medication Impact
  • Skin Diseases and Diabetes

Centre Hospitalier Victor Dupouy
2016-2025

Groupe de Recherche sur le Psoriasis
2020-2024

RELX Group (United States)
2023

Société Française de Cardiologie
2020-2023

École Nationale Supérieure des Arts Décoratifs
2023

Oxfam
2021

John Wiley & Sons (United States)
2021

Hudson Institute
2021

John Wiley & Sons (United Kingdom)
2021

Hopitaux Civils de Colmar
2020

Satveer K. Mahil Nick Dand K.J. Mason Z.Z.N. Yiu Teresa Tsakok and 95 more Freya Meynell Bola Coker Helen McAteer Lucy Moorhead Teena Mackenzie Mariateresa Rossi R. Rivera E. Mahé Andrea Carugno Michela Magnano Giulia Rech Esther A. Balogh Steven R. Feldman Claudia de la Cruz Siew Eng Choon Luigi Naldi Jo Lambert Phyllis I. Spuls D. Jullien H. Bachelez Devon E. McMahon Esther E. Freeman Paolo Gisondi L. Puig Richard B. Warren Paola Di Meglio Sinéad Langan Francesca Capon C.E.M. Griffiths Juliet N. Barker Catherine Smith Aadarsh Shah Alberto Barea Alberto Romero‐Maté Alekya Singapore Alexandra Paolino Alice Mwale Ana Maria Morales Callaghan A. J. Martinez Andrew J. DeCrescenzo Andrew Pink Ann Jones Ann Sergeant Annette Essex Anthony Bewley A. Makrygeorgou Astrid M. van Huizen Beatriz Pérez‐Suárez Farida Benhadou Birgitta Wilson Claréus Carla Tubau Prims Carrie L. Davis Catherine Quinlan Catriona Maybury Gonzalez A. Cesar Charlotte Barclay Claudio Greco Danielle Brassard Deanna Cummings Deepti Kolli V. Descamps Diana Ruíz Genao Efrossini Carras Elena B. Hawryluk Eliseo Martínez‐García Elżbieta Kłujszo Emily Dwyer Emmanuel Toni Enikö Sonkoly Enrique Loayza E. Daudén Fernando Valenzuela G Popov Georgie King Girard Celine Gloria Aparicio Graham A.R. Johnston Gustavo Anibal Cardozo Ian Pearson I. Yanguas Jamie Weisman Jennifer E. Carolan Jenny Hughes José María Ortiz Salvador J.M. Carrascosa Joseph J. Schwartz Karina Jackson Kathryn G. Kerisit K. Wu Leila Asfour Leontien de Graaf Cécile Lesort L. Meuleman Liv Eidsmo Lone Skov

10.1016/j.jaci.2020.10.007 article EN Journal of Allergy and Clinical Immunology 2020-10-16

Few prospective studies are available on the incidence and analysis of characteristics adverse cutaneous drug reactions in hospital settings.A 6-month study was managed our among hospitalized patients to: (i) evaluate allergic from systemic drugs; (ii) with reactions; (iii) describe (iv) reaction imputability preventability.All suspected to drugs were collected during a period (November 2000 May 2001). Exhaustivity recording ensured by regular dissemination information about this...

10.1111/j.1365-2133.2003.05584.x article EN British Journal of Dermatology 2003-11-01

Dear Editor We read with interest the publications in JEADV which reported dermatological manifestations associated COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs or chilblain-like lesions.1-6 Herein, we report two life-threatening cases of children presenting fever and eruptions mucous membrane involvement – erythema multiforme Kawasaki disease COVID-19. Case 1: A 6-year-old male was hospitalized for painful cheilitis that develops during week before admission rapidly...

10.1111/jdv.16666 article EN Journal of the European Academy of Dermatology and Venereology 2020-05-26

Scabies is a frequent condition seen in infants and children. Only topical treatments have been approved infants, but some of them are poorly tolerated. Oral ivermectin for the treatment scabies several countries, its use children weighing < 15 kg off label. To assess safety young children, to collect data on efficacy these age groups. This study was performed dermatology paediatric departments 28 French centres between July 2012 November 2015. Physicians treating an infant or child with...

10.1111/bjd.18369 article EN British Journal of Dermatology 2019-07-25

Use of systemic therapies for moderate to severe psoriasis in children is increasing, but comparative data on their use and toxicities are limited.To assess patterns relative risks agents children.A retrospective review was conducted at 20 centers North America Europe, included all consecutive with who used medications or phototherapy least 3 months from December 1, 1990, September 16, 2014.The minimal core set age, sex, severity psoriasis, interventions, monitoring, adverse events (AEs),...

10.1001/jamadermatol.2017.3029 article EN JAMA Dermatology 2017-09-13

Subcutaneous fat necrosis (SFN) of the newborn is a rare acute transient hypodermatitis that develops within first weeks life in term infants. It often follows difficult delivery. Prognosis generally good except for development hypercalcaemia severe cases. Only several case reports or small patients series have been published.To evaluate risk factors, complications and outcomes SFN 16 consecutive seen from 1996 to 2002 our Department Paediatric Dermatology.On case-report form created study,...

10.1111/j.1365-2133.2007.07782.x article EN British Journal of Dermatology 2007-03-20

Propranolol is now widely used to treat severe infantile haemangiomas (IHs). Very few cases of propranolol-resistant IH (PRIH) are mentioned in the literature.To describe characteristics PRIHs.A national, multicentre, retrospective, observational study was conducted from February 2011 December 2011. All patients with PRIH evaluated by members Groupe de Recherche Clinique en Dermatologie Pédiatrique 1 January 2007 were eligible.Among 1130 treated propranolol for haemangioma, 10 (0.9%) had...

10.1111/bjd.12417 article EN British Journal of Dermatology 2013-05-09

Summary Association of drug‐induced hypersensitivity syndrome with viral infection is debated. Human herpesvirus 6 (HHV‐6) reactivation has been the most frequently reported associated this syndrome. However, a case cytomegalovirus (CMV) was recently described anticonvulsant‐induced We report severe allopurinol‐induced pancreatitis Epstein–Barr virus (EBV) infection. Active EBV demonstrated in two consecutive serum samples by presence anti‐EBV early antigen (EA) IgM antibodies and an...

10.1046/j.1365-2133.2003.05330.x article EN British Journal of Dermatology 2003-05-01

Abstract Background Age of the patients and age onset psoriasis may have an impact on disease. There is little information about in elderly patients. Objective We evaluated epidemiological, clinical aspects, comorbidities treatments (&gt;70 years) patients, with very late (onset ≥ 70 years). Methods This observational multicentre non‐interventional study adults was conducted 29 departments dermatology France. A total 2210 were included. Results 212 (9.5%) elderly. group had a higher...

10.1111/jdv.12850 article EN Journal of the European Academy of Dermatology and Venereology 2014-11-11

Journal Article Psoriasis and obesity in French children: a case–control, multicentre study Get access E. Mahé, Mahé Service de Dermatologie Hôpital Victor Dupouy 69 rue du Lieutenant‐Colonel Prud'hon 95100 Argenteuil France Correspondence Emmanuel Mahé. E‐mail: emmanuel.mahe@ch-argenteuil.fr Search for other works by this author on: Oxford Academic Google Scholar A. Beauchet, Beauchet Département Santé Publique Centre Hospitalier Universitaire Ambroise Paré Université...

10.1111/bjd.13507 article FR British Journal of Dermatology 2014-10-31

Abstract Background/Objectives Little information is available on the prevalence and clinical aspects of nail involvement in children with psoriasis. The objective this study was to evaluate risk factors for French Methods We performed a multicenter, cross‐sectional 23 dermatology centers. All seen during 1‐year were systematically included. Clinical features nails collected. Association disease comorbidities evaluated. Results Of 313 psoriasis (mean age 9.1 ± 4.2 yrs; 149 boys, 164 girls),...

10.1111/pde.13028 article EN Pediatric Dermatology 2016-11-22

Excessive ultraviolet (UV) radiation exposure can cause skin cancers, photoageing and cataracts. Children are targeted by sun-protection campaigns because high sun sunburn in childhood increase the risk of melanoma adulthood. Little information is available about UV children who take part outdoor sports.To evaluate developing radiation-induced lesions run practise sports, measures during a soccer tournament.Firstly, we evaluated relationship between melanocytic naevus - lesion linked with to...

10.1111/j.1365-2133.2011.10415.x article EN British Journal of Dermatology 2011-05-17

Journal Article Childhood‐onset psoriasis: association with future cardiovascular and metabolic comorbidities Get access E. Mahé, Mahé Department of Dermatology Hôpital Victor Dupouy Argenteuil France Correspondence Emmanuel E‐mail: emmanuel.mahe@ch-argenteuil.fr Search for other works by this author on: Oxford Academic Google Scholar F. Maccari, Maccari d'Instruction des Armées Bégin Saint‐Mandé A. Beauchet, Beauchet Public Health Centre Hospitalier Universitaire Ambroise Paré University...

10.1111/bjd.12441 article EN British Journal of Dermatology 2013-08-12

Abstract Background Numerous inclusion and exclusion criteria are involved in phase III moderate to severe psoriasis trials investigating the safety efficacy of biologics. This questions generalization results. Methods In this cohort study, we applied inclusion/exclusion for from original protocols (adalimumab – REVEAL, ustekinumab PHOENIX, brodalumab AMAGINE, secukinumab FIXTURE) all patients enrolled PsoBioTeq prospective registry who received a biological agent first time between July...

10.1111/jdv.15878 article EN Journal of the European Academy of Dermatology and Venereology 2019-08-16

<h3>Importance</h3> Few studies have compared the use of methotrexate and biologics, most commonly used systemic medications for treatment moderate to severe psoriasis in children. <h3>Objective</h3> To assess real-world, 6-month reduction severity long-term drug survival (rate duration adherence a specific drug) vs biologics plaque <h3>Design, Setting, Participants</h3> A retrospective medical records review was conducted at 20 European North American centers. Treatment response based on...

10.1001/jamadermatol.2019.4835 article EN JAMA Dermatology 2020-02-05
Coming Soon ...